Sulfamethoxazole

Especificaciones

723-46-6Número CAS

211-963-3Número CE

4-amino-N-(5-methyl-1,2-oxazol-3-yl)benzenesulfonamideNombre IUPAC

C10H11N3O3SFórmula química

253.28 g/molPeso molecular

sulfamethoxazole; 723-46-6; Gantanol; Sulphamethoxazole; Sulfisomezole; Sulfamethoxazol; 4-Amino-N-(5-methyl-3-isoxazolyl)benzenesulfonamide; Radonil; Sinomin; Sulfamethylisoxazole; 4-amino-N-(5-methylisoxazol-3-yl)benzenesulfonamide; Sulfamethalazole; Azo-gantanol; Urobak; Sulfamethoxizole; Gantanol-DS; Ro 4-2130; Sulfametoxazol; Gamazole; 3-Sulfanilamido-5-methylisoxazole; Sulfamethoxazolum; 4-amino-N-(5-methyl-1,2-oxazol-3-yl)benzenesulfonamide; Benzenesulfonamide, 4-amino-N-(5-methyl-3-isoxazolyl)-; 5-Methyl-3-sulfanilamidoisoxazole; MS 53; 3-(p-Aminophenylsulfonamido)-5-methylisoxazole; 3-(para-Aminophenylsulphonamido)-5-methylisoxazole; DTXSID8026064; Sulfanilamide, N1-(5-methyl-3-isoxazolyl)-; Ro-4-2130; STX-608; 4-amino-N-(5-methyl-1,2-oxazol-3-yl)benzene-1-sulfonamide; Sulfanilamide, N'-(5-methyl-3-isoxazolyl)-; NSC-147832; CHEBI:9332; JE42381TNV; NSC147832; Sulfanilamide, N(1)-(5-methyl-3-isoxazolyl)-; DTXCID006064; sulfametoxazolo; Suphamethoxazole; RefChem:6502; J01EC01; 211-963-3; 656-929-2; Metoxal; Simsinomin; Sulphamethoxazol; Sulpha-methoxizole; Bactrim; Sulphamethylisoxazole; Sulphisomezole; 3-Sulphanilamido-5-methylisoxazole; 5-Methyl-3-sulphanil-amidoisoxazole; 5-Methyl-3-sulfanylamidoisoxazole; N'-(5-Methyl-3-isoxazolyl)sulfanilamide; N1-(5-Methyl-3-isoxazolyl)sulfanilamide; N'-(5-Methylisoxazol-3-yl)sulphanilamide; Sulfamethoprim; Sulmeprim; SMX; Trimeth/Sulfa; A047; MFCD00010546; N(sup 1)-(5-Methyl-3-isoxazolyl)sulphanilamide; N'-(5-Methyl-3-isoxazole)sulfanilamide; Ro 6-2580/11; 4-Amino-N-(5-methyl-isoxazol-3-yl)-benzenesulfonamide; N(sup 1)-(5-Methyl-3-isoxazolyl)sulfanilamide; CHEMBL443; MLS000069732; Solfametossazolo; N(sup1)-(5-Methyl-3-isoxazolyl)sulfanilamide; 5-Methyl-3-sulfonylamidoisoxazole; 3-(p-Aminobenzenesulfonamido)-5-methylisoxazole; 3-METHYL-1-(4-SULFOAMIDOPHENYL)-5-PYRA&; s1915; 4-Amino-N-(5-methyl-3-isoxazolyl)-benzenesulfonamide; NCGC00016533-05; NCGC00186654-01; CAS-723-46-6; SMR000058223; Solfametossazolo [DCIT]; 144930-01-8; [(4-aminophenyl)sulfonyl](5-methylisoxazol-3-yl)amine; Sulfametoxazol [INN-Spanish]; Sulfamethoxazolum [INN-Latin]; CCRIS 567; Sulfamethoxazole CRS; HSDB 3186; SR-01000000217; EINECS 211-963-3; NSC 147832; BRN 0226453; ulfamethoxazole; UNII-JE42381TNV; Sulfamethoxazole; 4-Amino-N-(5-methylisoxazol-3-yl)benzenesulfonamide; Sulfamethoxazole RS; 08D; Prestwick_453; ALBB-002089; Sulfamethoxazole/SMZ; Septran (Salt/Mix); Septrin (Salt/Mix); Eusaprim (Salt/Mix); RP-2145; Spectrum_000994; Sulfamethoxazole(USAN); starbld0000281; Opera_ID_882; Maybridge1_007190; Prestwick0_000177; Prestwick1_000177; Prestwick2_000177; Prestwick3_000177; Spectrum2_000788; Spectrum3_000584; Spectrum4_000345; Spectrum5_000982; Sulfamethoxazole [USAN:USP:INN:BAN:JAN]; Epitope ID:114999; Co-trimoxazole (Salt/Mix); Sulfamethoxazole (Standard); SCHEMBL3656; Oprea1_114486; Oprea1_285680; BSPBio_000073; BSPBio_002028; KBioGR_000749; KBioSS_001474; SULFAMETHOXAZOLE [MI]; MLS001055354; MLS001074165; MLS006011871; BIDD:GT0731; DivK1c_000649; SPECTRUM1500550; SULFAMETHOXAZOLE [INN]; SULFAMETHOXAZOLE [JAN]; SPBio_000896; SPBio_001994; SULFAMETHOXAZOLE [HSDB]; SULFAMETHOXAZOLE [IARC]; SULFAMETHOXAZOLE [USAN]; BPBio1_000081; orb1224143; orb1310200; orb3025068; SULFAMETHOXAZOLE [VANDF]; SULFAMETHOXAZOLE [MART.]; component of Bactrim (Salt/Mix); GTPL10933; HMS502A11; HMS561O18; HY-B0322R; JLKIGFTWXXRPMT-UHFFFAOYSA-; KBio1_000649; KBio2_001474; KBio2_004042; KBio2_006610; KBio3_001528; MSK4005; SULFAMETHOXAZOLE [USP-RS]; SULFAMETHOXAZOLE [WHO-DD]; SULFAMETHOXAZOLE [WHO-IP]; WLN: T5NOJ C1 EMSWR DZ; NINDS_000649; GLXC-07765; HMS1568D15; HMS1921A21; HMS2092K03; HMS2095D15; HMS2233L13; HMS3259E06; HMS3372M22; HMS3655O22; HMS3712D15; HMS5080B05; Pharmakon1600-01500550; SMSSF-0062965; HY-B0322; Sulfamethoxazole (JP17/USP/INN); VQB71986; Sulfamethoxazole, analytical standard; Tox21_110480; Tox21_200353; BBL004554; BDBM50029770; CCG-40166; EBC-03728; MSK4005-100A; NSC757328; Ro-42130; SBB057675; SBB071655; STK007988; SULFAMETHOXAZOLE [ORANGE BOOK]; AKOS000200952; component of Azo Gantanol (Salt/Mix); MSK4005-1000A; Tox21_110480_1; BS-3542; DB01015; FS27933; NC00537; NSC-757328; SULFAMETHOXAZOLE [EP MONOGRAPH]; COTRIM COMPONENT SULFAMETHOXAZOLE; IDI1_000649; SEPTRA COMPONENT SULFAMETHOXAZOLE; SULFAMETHOXAZOLE [USP MONOGRAPH]; SULFAMETHOXAZOLUM [WHO-IP LATIN]; BACTRIM COMPONENT SULFAMETHOXAZOLE; NCGC00016533-01; NCGC00016533-02; NCGC00016533-03; NCGC00016533-04; NCGC00016533-06; NCGC00016533-07; NCGC00016533-08; NCGC00016533-09; NCGC00016533-10; NCGC00016533-11; NCGC00016533-12; NCGC00016533-14; NCGC00016533-23; NCGC00016533-24; NCGC00021995-03; NCGC00021995-04; NCGC00021995-05; NCGC00257907-01; UROPLUS COMPONENT SULFAMETHOXAZOLE; AC-11118; ST024740; SY018888; N'-(5-Methyl-3-isoxazolyl)-Sulfanilamide; N1-(5-methyl-3-isoxazolyl)-Sulfanilamide; N1-(5-Methyl-3-isoxazolyl)sulphanilamide; SBI-0051524.P003; SULFATRIM COMPONENT SULFAMETHOXAZOLE; SULMEPRIM COMPONENT SULFAMETHOXAZOLE; BACTRIM DS COMPONENT SULFAMETHOXAZOLE; Co-trimethoxazole component sulfamethoxazole; DB-055629; AB00052099; N^1-(5-Methyl-3-isoxazolyl)-Sulfanilamide; NS00000268; ST51006798; Sulfamethoxazole 100 |Ig/mL in Acetonitrile; Sulfamethoxazole 1000 microg/mL in Methanol; SW196670-3; AZO GANTANOL COMPONENT SULFAMETHOXAZOLE; COTRIM D.S. COMPONENT SULFAMETHOXAZOLE; EN300-18400; C07315; D00447; F12027; SULFAMETHOPRIM COMPONENT SULFAMETHOXAZOLE; Sulfamethoxazole 100 microg/mL in Acetonitrile; AB00052099-14; AB00052099-16; AB00052099_17; AB00052099_18; Sulfamethoxazole 1000 microg/mL in Acetonitrile; BACTRIM PEDIATRIC COMPONENT SULFAMETHOXAZOLE; F236656; F572237; Ndimethyl1-(5-methyl-3-isoxazolyl)-Sulfanilamide; Q415843; SR-01000000217-2; SR-01000000217-3; Sulfamethoxazole Solution in Acetonitrile, 100ug/mL; Sulfamethoxazole, VETRANAL(TM), analytical standard; BRD-K28494619-001-05-0; BRD-K28494619-001-15-9; BRD-K28494619-001-26-6; BRD-K28494619-001-27-4; BRD-K28494619-001-28-2; Sulfamethoxazole Solution in Acetonitrile, 1000ug/mL; Z57198677; F0175-0013; Sulfamethoxazole, British Pharmacopoeia (BP) Reference Standard; Sulfamethoxazole, certified reference material, TraceCERT(R); 4-amino-N-(5-methyl-1,2-oxazol-3-yl)benzenesulfonamide; SMX; SMZ; p-aminophenyl(5-methyl-3-isoxazolylamino)(oxo)-lambda-sulfaniumolate; Sulfamethoxazole, European Pharmacopoeia (EP) Reference Standard; Sulfamethoxazole, United States Pharmacopeia (USP) Reference Standard; Sulfamethoxazole, Pharmaceutical Secondary Standard; Certified Reference Material; InChI=1/C10H11N3O3S/c1-7-6-10(12-16-7)13-17(14,15)9-4-2-8(11)3-5-9/h2-6H,11H2,1H3,(H,12,13)Sinónimos